Brief: Enanta Pharmaceuticals Q4 Revenue USD 15.125 Million
17/11/2025 21:01
Nov 17 (Reuters) - Enanta Pharmaceuticals Q4 pretax profit USD -18.668 million. Q4 operating income USD -18.386 million Q4 net income USD -18.7 million Q4 operating expenses USD 33.511 million
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates